STOCK TITAN

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

GRAIL (Nasdaq: GRAL) announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

Live and replay webcasts will be available via the company's investor relations site at investors.grail.com, and the webcast will be archived and available for replay for at least 30 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 3 Alerts

+4.90% News Effect
+$141M Valuation Impact
$3.03B Market Cap
0.1x Rel. Volume

On the day this news was published, GRAL gained 4.90%, reflecting a moderate positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $141M to the company's valuation, bringing the market cap to $3.03B at that time.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18 at 10:00 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-7th-annual-wolfe-research-healthcare-conference-302604500.html

SOURCE GRAIL, Inc.

FAQ

When will GRAIL (GRAL) present at the Wolfe Research Healthcare Conference?

GRAIL will present on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

How can investors watch the GRAIL (GRAL) presentation on Nov. 18, 2025?

Investors can access the live webcast and replays via the investor relations site at investors.grail.com.

Will the GRAIL (GRAL) webcast be available after the Wolfe Research conference?

Yes, the webcast will be archived and available for replay for at least 30 days after the event.

Where on the GRAIL website will the Wolfe Research webcast appear?

The webcast will be posted in the Investor Relations section of investors.grail.com.

Is there any fee or special registration mentioned to view the GRAIL (GRAL) webcast?

No fee or special registration is mentioned; the announcement directs viewers to the investor relations site.

What time zone is used for the GRAIL (GRAL) conference presentation time?

The presentation time is shown in Eastern Time (ET).
Grail Inc

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Latest SEC Filings

GRAL Stock Data

3.58B
35.08M
13.81%
73.53%
13.42%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MENLO PARK